Richard Scott Struthers, President & CEO at Crinetics Pharmaceuticals, Inc. (CRNX), sold 100,000 shares at $20.81 ($2.1M) on 2023-06-16, disclosed to the SEC on 2023-06-21.
Scheduled sale ($2.1M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.81 | 50,000 | $1.0M | 50.0% |
| 2 | $20.81 | 50,000 | $1.0M | 50.0% |
| Total | $20.81 avg | 100,000 | $2.1M | 100% |
| Filing → |
| CRNX | SELL | 2025-03-21 | $1.2M | — | Filing → |
| CRNX | SELL | 2024-12-04 | $576K | — | Filing → |
| CRNX | SELL | 2024-05-10 | $10.6M | — | Filing → |